Potential for improvement in cancer management: Reducing mortality in the European Union

Oncologist

Volumn 20, Issue 5, 2015, Pages 495-498

  La Vecchia, Carlo ^a   Rota, Matteo ^b   Malvezzi, Matteo ^a,b   Negri, Eva ^b  

^a UNIVERSITY OF MILAN   (Italy)

^b MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

Author keywords

Avoidable deaths; Cancer diagnosis; Cancer mortality; Cancer survival; Cancer therapy; Tobacco

Indexed keywords

ARTICLE; CANCER DIAGNOSIS; CANCER MORTALITY; CANCER STAGING; CANCER SURVIVAL; CANCER THERAPY; ENVIRONMENTAL EXPOSURE; EUROPEAN UNION; FEMALE; HEALTH CARE DELIVERY; HUMAN; INFORMATION PROCESSING; LIFESTYLE; MALE; PRIORITY JOURNAL; TOBACCO; ADULT; ADVERSE EFFECTS; AGED; DISEASE MANAGEMENT; MIDDLE AGED; MORTALITY; NEOPLASMS; SURVIVAL RATE; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; DISEASE MANAGEMENT; EUROPEAN UNION; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; SURVIVAL RATE; TOBACCO;

EID: 84929085391     PISSN: 10837159     EISSN: 1549490X     Source Type: Journal    
DOI: 10.1634/theoncologist.2015-0011     Document Type: Article

References (27)

1. Bosetti C, Bertuccio P, Malvezzi M et al. Cancer mortality in Europe, 2005-2009, and an overview of trends since 1980. Ann Oncol 2013;24:2657-2671.
2. Levi F, Lucchini F, Negri E et al. Cervical cancer mortality in young women in Europe: Patterns and trends. Eur J Cancer 2000;36:2266-2271.
3. Levi F, Lucchini F, Boyle P et al. Testicular cancer mortality in Eastern Europe. Int J Cancer 2003;105:574.
4. Bosetti C, Levi F, Ferlay J et al. The recent decline in mortality from Hodgkin lymphomasin central and eastern Europe. Ann Oncol 2009;20:767-774.
5. Siegel R, Ma J, Zou Z et al. Cancer statistics, 2014. CA Cancer J Clin 2014;64:9-29.
6. Soneji S, Beltrán-Sánchez H, Sox HC. Assessing progress in reducing the burden of cancer mortality, 1985-2005. J Clin Oncol 2014;32:444-448.
7. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015. CA Cancer J Clin 2015;65:5-29.
8. De Angelis R, Sant M, Coleman MP et al. Cancer survival in Europe 1999-2007 by country and age: Results of EUROCARE-5-a population-based study. Lancet Oncol 2014;15:23-34.
9. Survival of cancer patients in Europe the EUROCARE-5 study. Section 1: Survival analysis 2000 - 2007. Available at https://w3.iss.it/site/EU5Results/. Accessed December 23, 2014.
10. Malvezzi M, Bertuccio P, Levi F et al. European cancer mortality predictions for the year 2014. Ann Oncol 2014;25:1650-1656.
11. Malvezzi M, Bertuccio P, Rosso T et al. European cancer mortality predictions for the year 2015: Does lung cancer have the highest death rate inEUwomen? Ann Oncol 2015;26:779-786.
12. WHO Statistical Information System (WHOSIS). Available at http://www3.who.int/whosis/menu.cfm/. Accessed September 2014.
13. La Vecchia C, Bosetti C, Bertuccio Pet al.Trends in alcohol consumption in Europe and their impact on major alcohol-related cancers. Eur J Cancer Prev 2014;23:319-322.
14. Bertuccio P, Bosetti C, Malvezzi M et al. Trends in mortality from leukemia in Europe: An update to 2009 andaprojectionto2012. Int J Cancer 2013;132:427-436.
15. Hawkes N. Many cancer deaths could be eliminated by greater awareness and access to latest treatments, report says. BMJ 2015;350:h223.
16. Sunkara V, Hébert JR. The colorectal cancer mortality-to-incidence ratio as an indicator of global cancer screening and care. Cancer 2015 [Epub ahead of print].
17. Bosetti C, Bertuccio P, Levi F et al.The decline in breast cancer mortality in Europe: An update (to 2009). Breast 2012;21:77-82.
18. Negri E, Zambelli A, Franchi M et al. Effectiveness of trastuzumab in first-line HER21 metastatic breast cancer after failure in adjuvant setting: A controlled cohort study. The Oncologist 2014;19:1209-1215.
19. Bosetti C, Levi F,RosatoVet al.Recenttrends in colorectal cancer mortality in Europe. Int J Cancer 2011;129:180-191.
20. Rougier P, Mitry E. Epidemiology, treatment and chemoprevention in colorectal cancer. Ann Oncol 2003;14(suppl 2):ii3-ii5.
21. Etzioni R, Gulati R,TsodikovAet al.Theprostate cancer conundrum revisited: Treatment changes and prostate cancer mortality declines. Cancer 2012;118:5955-5963.
22. Cuzick J, Thorat MA, Andriole G et al. Prevention and early detection of prostate cancer. Lancet Oncol 2014;15:e484-e492.
23. Abdel-Rahman M, Stockton D, Rachet B et al. What if cancer survival in Britainwere the same as in Europe: How many deaths are avoidable? Br J Cancer 2009;101(suppl 2):S115-S124.
24. Ellis L, Coleman MP, Rachet B. How many deaths would be avoidable if socioeconomic inequalities in cancer survival in Englandwere eliminated? Anational population-based study, 1996-2006. Eur J Cancer 2012;48:270-278.
25. Levi F, Lucchini F, Negri E et al. Trends in mortality from major cancers in the European Union, including acceding countries, in 2004. Cancer 2004;101:2843-2850.
26. Quaglia A, Tavilla A, Shack L et al. The cancer survival gap between elderly and middle-aged patients in Europe is widening. Eur J Cancer 2009; 45:1006-1016.
27. Lawler M, Selby P, Aapro MS et al. Ageism in cancer care. BMJ 2014;348:g1614.